Navigation Links
IncentOne Announces Flu Prevention Rewards Program™
Date:8/20/2008

IncentOne, the leading provider of integrated incentive administration solutions, announced today that it is offering a "Flu Prevention Rewards Program™" to increase participation in employer, health plan and other health care provider sponsored flu shot and other flu vaccine programs.

Lyndhurst, NJ (PRWEB) August 20, 2008 -- www.incentone.com [IncentOne]], the leading provider of integrated incentive administration solutions, announced today that it is offering a "Flu Prevention Rewards Program™" to increase participation in employer, health plan and other health care provider sponsored flu shot and other flu vaccine programs.

The impact of the flu is widespread - from corporations to families to health care costs. Direct medical costs related to the flu are estimated to be as high as $10.4 billion annually, with lost school days, work days and productivity estimated at $71-$167 billion annually. The Flu Prevention Rewards Program has been designed to drive the participation rate in company or health care provider sponsored flu shot and vaccine programs in efforts to reduce the staggering overall costs associated with this debilitating illness.

With the flu season quickly approaching the Centers for Disease Control and Prevention advises that the single best way to protect against the flu is to get vaccinated each year beginning in September and throughout the flu season, into January, February and beyond.

IncentOne's Flu Prevention Rewards Program utilizes a powerful, web-based incentive solution that enables employers, health plans and other health care providers to issue an award to employees or members for getting a flu vaccine. Program participants that have gotten their flu vaccine will receive their award electronically through email or paper through U.S. mail that can be easily redeemed online or by calling the program hotline, choosing from numerous gift cards, merchandise, healthy rewards and more.

The website and award can be customized with company or health plan branding, logo, content and personalized messaging. The website also enables polling, tracking, reporting, custom reward options and other features.

"Flu vaccine programs have demonstrated clear economic benefits", says Michael Dermer, CEO and President of IncentOne. "By using IncentOne's data and collaborating with its industry-leading customers and partners, IncentOne has developed a program to drive participation in flu vaccine programs to both prevent illness and reduce health care costs for health plans, governments and employers."

About IncentOne
IncentOne provides integrated incentive solutions to employers, health plans and partners. IncentOne's technology-based solutions provide the tools to drive productivity improvement and health care cost reduction. For more information, please visit www.IncentOne.com.

# # #

Read the full story at http://www.prweb.com/releases/2008/08/prweb1224104.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. IncentOne Builds More Client Flexibility, Employee Choices Into Its Health Incentive Solutions
2. IncentOne Adds 14 New Clients Year to Date to Health and Productivity Division
3. IncentOne Receives Incentive Platinum Partner Award
4. IncentOnes Sue Lewis brings "The Art and Science of Incentive Management" to AHIP Business Forum
5. ModernMed Announces Partnership With Dr. Neil J. Sapin, M.D.
6. Onward Healthcare Announces Recertification by The Joint Commission
7. NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
8. VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy
9. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
10. Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis
11. Dr. Lisa Zdinak Announces, CO2TouchTM Brazilian Carboxytherapy - New Technology for Non-Surgical Treatment of Stretch Marks, Cellulite and Dark Undereye Circles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Huntington Beach, CA (PRWEB) , ... January 19, ... ... for Oral Health, is now offering treatments for patients with sleep apnea and ... far-reaching consequences for dental and physical health. Dr. Rassouli provides personalized care to ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... protection and financial planning services to communities throughout eastern Georgia, is embarking on ... heart disease. , Heart disease kills more Americans every year than anything else, ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages to prevent ... contest from Impact Teen Drivers and California Casualty. Entries from students aged 14-22 ... grants totaling $15,000 will be awarded for the best peer-to-peer messages sharing solutions ...
(Date:1/19/2017)... ... 19, 2017 , ... The 21st Century Cures Act’s Impact on Medical Devices:, ... 2016 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , ... to thrive this year? , The passage of the act means devicemakers will be ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... American Osteopathic College of Proctology) announced today the opening of 3 medical ... ( http://www.hemorrhoidsremovalcenterscalifornia.com ): Hemorrhoids Center of Los Angeles (Beverly Hills), Hemorrhoids Center ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Abaxis, Inc. (NasdaqGS: ... blood analysis instruments and consumables for the medical and ... discuss its financial results for the third quarter fiscal ... be at 4:15 p.m. ET on Thursday, January 26, ... third quarter fiscal year 2017 after the market closes ...
(Date:1/19/2017)... 2017 Shire plc (LSE: SHP, ... Food and Drug Administration (FDA) has acknowledged receipt of ... (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine salts ... treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected ... 2017, the designated Prescription Drug User Fee Act (PDUFA) ...
(Date:1/19/2017)... January 19, 2017 While ... serious about reducing the FDA,s regulatory strictness as ... the medical drug industry, many of the leading ... clinical trials and development of advanced drug treatments ... with recent developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: